Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
The Scientist
Most Recent
A paper describing a new method for imaging synapse formation has been retracted after it emerged that the first author falsified data to prove its effectiveness.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
A Case Western Reserve University researcher is found guilty of altering the number of samples and results to inflate the statistical significance of his findings.
Meet the bacterium that pulls gold ions out of solution and forms tiny nuggets of the precious metal.
Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.
As cholera first tore through the Europe in the mid-19th century, people tried anything to prevent the deadly disease. Then science stepped in.
With dogged persistence and an unwillingness to entertain defeat, Bruce Beutler discovered a receptor that powers the innate immune response to infections—and earned his share of a Nobel Prize.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
